Paola Azzoni

Paola Azzoni

Auto-generated profile, based on publicly available information

Paola Azzoni

University of Modena and Reggio Emilia, Department of Surgery, Medicine Dentistry and Morphological Sciences with Interest in Transplant, Modena, Italy

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1995 in Biology of Reproduction
Verified
Journal Article
Closed access
GMGian Carlo Manicardi
Gian Carlo Manicardi
PBP. G. Bianchi
P. G. Bianchi
SPS. Pantano
S. Pantano
PAP. Azzoni
P. Azzoni
DBD. Bizzaro
D. Bizzaro
DSD. Sakkas
D. Sakkas
During spermiogenesis, mammalian chromatin undergoes replacement of nuclear histones by protamines, resulting in a DNA that is highly condensed in the mature sperm. We have previously demonstrated that a percentage of human spermatozoa exhibit 1) positivity to the guanine-cylosine-specific chromomycin A3 (CMA3) fluorochrome and 2) the presence of endogenous nicks in their DNA. In situ protamination of mature human sperm limits the percentage of sperm positive to CMA3 and exhibiting endogenous nicks. In this study, we report further investigations that aim to clarify the relationship existing between levels of CMA3 stainability and the presence of endogenous nicks in the DNA of mature human spermatozoa. Human spermatozoa from 25 different samples showed values of sensitivity to the CMA3 fluorochrome ranging from 13% to 75%. The same samples showed a percentage of sensitivity to endogenous nick translation ranging from 1% to 38%. A strong correlation (r = 0.86) was evident between these two parameters. Prior staining of sperm with the CMA3 fluorochrome drastically reduced sensitivity to nick translation. In contrast, previously nick-translated sperm stained with CMA3 showed very little difference from samples that had not been pretreated. The presence of nicked sperm in the ejaculate may indicate anomalies during spermiogenesis and be an indicator of male infertility.

1 May 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HBHagar Bessar
Hagar Bessar
Iole VendittiIole Venditti
Iole Venditti
LBLuisa Benassi
Luisa Benassi
CVCristina Vaschieri
Cristina Vaschieri
PAPaola Azzoni
Paola Azzoni
Ilaria FratoddiIlaria Fratoddi
Ilaria Fratoddi

28 January 2011 in Cytogenetic and Genome Research
Verified
Journal Article
Open access
Mauro MandrioliMauro Mandrioli
Mauro Mandrioli
PAP. Azzoni
P. Azzoni
GLG. Lombardo
G. Lombardo
GMGian Carlo Manicardi
Gian Carlo Manicardi
A detailed karyotype analysis of the oleander aphid Aphis nerii focusing on the distribution, molecular composition and epigenetic modifications of heterochromatin was done in order to better understand the structure and evolution of holocentric/holokinetic chromosomes in aphids. The female karyotype (2n = 8) consisted of 3 pairs of autosomes and a pair of X chromosomes that were the longest elements in the karyotype and carried a single, terminally located nucleolar organizer region. Males showed 2n = 7 chromosomes due to the presence of a single X chromosome. Heterochromatin was located in the X chromosomes only and consisted of 4 satellite DNAs that have been identified. A. nerii constitutive heterochromatin was enriched in mono-, di- and tri-methylated H3 histones and HP1 proteins but, interestingly, it lacked DNA methylation that was widespread in euchromatic chromosomal regions. These results suggest that aphid heterochromatin is assembled and condensed without any involvement of DNA methylation.

1 March 2011 in Aquatic Toxicology
Verified
Journal Article
Closed access
MMMarco Marcheselli
Marco Marcheselli
PAPaola Azzoni
Paola Azzoni
MMMarina Mauri
Marina Mauri

12 November 2011 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
GPGiovanni Ponti
Giovanni Ponti
SNSabina Nasti
Sabina Nasti
Lorena LosiLorena Losi
Lorena Losi
Lorenza PastorinoLorenza Pastorino
Lorenza Pastorino
APAnnamaria Pollio
Annamaria Pollio
SSStefania Seidenari
Stefania Seidenari

1 March 2014 in Applied Immunohistochemistry & Molecular Morphology
Verified
Journal Article
Closed access
CMCristina Magnoni
Cristina Magnoni
SGStefania Giudice
Stefania Giudice
GPGiovanni Pellacani
Giovanni Pellacani
GBGiorgia Bertazzoni
Giorgia Bertazzoni
CLCaterina Longo
Caterina Longo
GPGiovanni Ponti
Giovanni Ponti
Cutaneous Melanoma is an extremely heterogeneous human cancer. The most aggressive melanoma may contain deregulated cells with undifferentiated/stem cell-like phenotype. A critical mechanism by which melanoma cells enhance their invasive capacity is the dissolution of the intercellular adhesions and the acquisition of mesenchymal features as a part of an epithelial-to-mesenchimal transition (EMT). The aim of this study was to clarify the role of stem cell-like population in human melanomas through the in vitro analysis of melanocytic cell cultures, obtained from distinct histotypes of primary and metastatic malignant melanoma. Patients with advanced melanoma larger than 2cm diameter and/or wider than 300mm2 surface were enrolled. The melanoma cells were isolated from skin biopsies of lentigo melanoma (LM), superficial spreading (SS), nodular melanoma (NM) and metastatic melanoma (MM) and maintained in different media in order to evaluate the colony-forming unit assay, alkaline phosphatase and toluidine blue stain and the cell ability to differentiate into osteogenic and adipogenic lineages. Immunohistochemistry and flow cytometry analysis were performed in order to evaluate antigenic markers CD90, CD73, CD105, CD146, CD20, CD166 and nestin.\ud This study confirms that melanoma can include an heterogeneous cell population with both abilities to self-renew and to give rise to differentiated progeny. Melanoma cells displayed the intra-tumoral heterogeneity and dynamic antigen phenotypes. Histologically, the transitions from normal skin to DN to LM to NM to MM was associated with a gradual increase in the expression of CD146, CD20, CD133, Nestin and CD73 by melanoma cells. These molecular evidences could be a milestone for the development of novel biomolecular targeted-therapy approaches